September 14, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces the successful results of the first surgical procedures using the Jazz Lock®. Having obtained CE marking and 510K clearance, Jazz Lock has been used in select […]